Suscripción a Biblioteca: Guest
Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones
Critical Reviews™ in Immunology
Factor de Impacto: 1.404 Factor de Impacto de 5 años: 3.347 SJR: 0.706 SNIP: 0.55 CiteScore™: 2.19

ISSN Imprimir: 1040-8401
ISSN En Línea: 2162-6472

Volumes:
Volumen 40, 2020 Volumen 39, 2019 Volumen 38, 2018 Volumen 37, 2017 Volumen 36, 2016 Volumen 35, 2015 Volumen 34, 2014 Volumen 33, 2013 Volumen 32, 2012 Volumen 31, 2011 Volumen 30, 2010 Volumen 29, 2009 Volumen 28, 2008 Volumen 27, 2007 Volumen 26, 2006 Volumen 25, 2005 Volumen 24, 2004 Volumen 23, 2003 Volumen 22, 2002 Volumen 21, 2001 Volumen 20, 2000 Volumen 19, 1999 Volumen 18, 1998 Volumen 17, 1997 Volumen 16, 1996 Volumen 15, 1995 Volumen 14, 1994

Critical Reviews™ in Immunology

DOI: 10.1615/CritRevImmunol.v27.i4.10
pages 291-302

PART II. Toxins as Therapeutic Agents
Alpha-Cobratoxin as a Possible Therapy for Multiple Sclerosis: A Review of the Literature Leading to Its Development for This Application

Paul F. Reid
ReceptoPharm Inc., Plantation, FL 33313, USA

SINOPSIS

The use of snake venom in the treatment of multiple sclerosis has been, at best, controversial. The anecdotal reports for snake venom's beneficial effects in this condition may be supportable now by recent scientific evidence. Cobratoxin, a neurotoxin obtained from the venom of the Thailand cobra, has demonstrated several pharmacological activities that strongly support its use in this application. By employing a chemical detoxification step, the neurotoxin can be rendered safe for administration to humans with minimal side effects. This modified neurotoxin has demonstrated neuromodulatory, antiviral, and analgesic activity, elements associated with the multiple sclerosis condition. Modified cobratoxin has demonstrated potent immunosuppressive activity in acute and chronic animal models of the disease. The drug is under investigation for use in adrenomyeloneuropathy and clinical trials in Multiple sclerosis are planned.


Articles with similar content:

Role of Exercise in Multiple Sclerosis: Potential Application of Adapted Exercise Modalities
Critical Reviews™ in Physical and Rehabilitation Medicine, Vol.23, 2011, issue 1-4
Lara A. Pilutti, Audrey L. Hicks
Immunotherapeutic Treatment of Autoimmune Diabetes
Critical Reviews™ in Immunology, Vol.33, 2013, issue 3
Jae Hyeon Kim, Hun Sik Kim, Sang-Man Jin, Myung-Shik Lee, Kyoung-Ah Kim
Psoriasis Clinical Implications and Treatment: A Review
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.30, 2013, issue 3
Ashlesha S. Raut, Vandana B. Patravale, Rashmi H. Prabhu
Exercise to Manage MS Fatigue: Counterintuitive Yet Effective
Critical Reviews™ in Physical and Rehabilitation Medicine, Vol.27, 2015, issue 2-4
A. V. Caprariello, K. M. Othonos, S. F. Kornfeld, Audrey L. Hicks
Possible Molecular Targets of Bee Venom in the Treatment of Cancer: Application and Perspectives
Forum on Immunopathological Diseases and Therapeutics, Vol.4, 2013, issue 3-4
Nada Orsolic